IPO Advisory

Strategic Advisor on Kestra Medical’s $232M Initial Public Offering

« Back

Backdrop
Kestra Medical Technologies (NASDAQ: KMTS) priced its $232M IPO on March 5, 2025. The upsized, double-digit oversubscribed IPO priced above the initial range and closed nearly 30% above pricing on its first day of trading.


Issuer: Kestra Medical Technologies, Ltd. (KMTS)
Offering Size (Gross): $232M
Initial Pricing Range: $14.00-$16.00
Offer Price: $17.00
First Trade Day Closing Price: $21.84 (+28%)


Gilmartin Role, Support & Execution

Pre-IPO

  • Messaging and positioning
  • Financial model analysis & forecast stress-testing
  • Investor relationship development
  • Sell-side relationship management
  • Conference/NDR management
  • Presentation/pitch development
  • Press release drafting
  • Peer benchmarking & KPI analysis
  • Valuation analysis
  • BOD communications
  • IPO readiness assessment
  • Banking syndicate advisory

IPO Execution

  • Bake-off & Org meeting prep
  • KPI strategy & TAM analysis
  • Analyst diligence & model preparation
  • S-1 drafting
  • TTW prep & targeting
  • Listing exchange selection
  • Roadshow presentation, script, recording, Q&A
  • Internal communications
  • IR website build Workflow/process management

Post-IPO Support

  • Strategic message evolution
  • Earnings materials development
  • Guidance & KPI strategy
  • Consensus model management
  • Shareholder analysis & targeting
  • Marketing / IR logistics
  • Investor conference/NDR support
  • PR drafting and distribution
  • Peer & industry surveillance / analysis
  • Ongoing capital markets advisory

Syndicate Composition

Our Clients

Our clients are leaders and innovators across the MedTech, Biotechnology, Digital Health, Life Science Tools & Diagnostic sectors

Learn More About Our Clients

Gilmartin Blog

Gilmartin has a number of resources, from blog posts to webinars designed to educate and help your company achieve success.

Explore Our Blog